The Division of Pharmacy at The University of Texas MD Anderson Cancer Center offers an ASHP accredited one-year PGY2 Oncology Pharmacy residency program. MD Anderson is a world renowned comprehensive cancer center. The institution has more than 650 inpatient beds and over 5000 outpatient clinic visits daily. Our structured PGY2 Oncology Pharmacy Residency Program is concentrated in direct patient care activities designed to develop clinical expertise and competence in the pharmacotherapeutic management of cancer patients. Core residency learning experiences provide exposure to a variety of solid tumor, malignant hematology, and stem cell transplant patient populations as well as elective time that will be tailored to the interests and career goals of the resident. Residents will also gain experience with oncology pharmacy operations, drug information, medication safety, investigational pharmacy services, clinical research, and education to health care professionals, patients, and the general public. Through these diverse experiences, residents will develop the skills necessary to become a successful and comprehensive oncology clinical pharmacy specialists.

Visit our website for more information: PGY2 Oncology Pharmacy Residency. Interested candidates should submit a request for a PPS interview to Jason Yeh, Director, PGY2 Oncology Pharmacy Residency Program through the CareerPharm system.

Benefits:

• MD Anderson Cancer Center is an Equal Opportunity Employer
• Employee free medical insurance
• Vacation, sick leave, and conference time
• No state income tax